Corrigendum: “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” (European Urology Focus (2021) 7(6) (1347–1354), (S240545692030208X), (10.1016/j.euf.2020.07.002))

Maria Carmen Mir, Michele Marchioni, Homi Zargar, K. Zargar-Shoshtari, A. S. Fairey, Laura S. Mertens, C. P. Dinney, L. M. Krabbe, M. S. Cookson, N. E. Jacobsen, J. Griffin, J. S. Montgomery, N. Vasdev, E. Y. Yu, E. Xylinas, J. S. McGrath, W. Kassouf, M. A. Dall'Era, S. S. Sridhar, J. AningS. F. Shariat, J. L. Wright, A. C. Thorpe, T. M. Morgan, J. M. Holzbeierlein, T. J. Bivalacqua, S. North, D. A. Barocas, Y. Lotan, P. Grivas, A. J. Stephenson, J. B. Shah, B. W. van Rhijn, P. E. Spiess, S. Daneshmand, P. C. Black

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original article, the name of author Sia Daneshmand was incorrectly abbreviated as D. Daneshmand. The correct version is given in the above author list. Conflicts of interest: The authors have nothing to disclose.

Original languageEnglish (US)
JournalEuropean Urology Focus
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Corrigendum: “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” (European Urology Focus (2021) 7(6) (1347–1354), (S240545692030208X), (10.1016/j.euf.2020.07.002))'. Together they form a unique fingerprint.

Cite this